Far-reaching Proposals For Reform On Table at World Health Assembly – But Will Member States Heed The Call? 20/05/2021 Elaine Ruth Fletcher With an agenda that is more packed than ever – and razor sharp political crises from Gaza to Taiwan to Myanmar also coming to the fore – will the upcoming World Health Assembly prove to be the decisive moment that it should be for global health? Now, more than ever perhaps, huge tensions and inequalities […] Continue reading -> New ‘One Health’ Expert Panel to Address Emergence and Spread of Zoonotic Diseases, as Risk of Zoonoses Rises 20/05/2021 Madeleine Hoecklin A new international expert panel launched by four international organisations on Thursday aims to blunt the emergence and spread of zoonotic diseases through better understanding of human, animal, and environmental interactions that enable animal-borne diseases to break into human populations. The One Health High Level Expert Panel will advise the World Health Organization (WHO), […] Continue reading -> Pandemic Treaty & Other New COVID Initiatives Grab Center Stage At World Health Assembly 20/05/2021 Pokuaa Oduro-Bonsrah Conquering the COVID-19 pandemic will inevitably be the main topic for discussion at the impending 74th session of the World Health Assembly, which begins Monday, 24 May. Global health experts weighed in this week at a series of briefings on what to expect from at the upcoming event. Geneva Solution’s Pokuaa Oduro Bonsrah reports: The […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New ‘One Health’ Expert Panel to Address Emergence and Spread of Zoonotic Diseases, as Risk of Zoonoses Rises 20/05/2021 Madeleine Hoecklin A new international expert panel launched by four international organisations on Thursday aims to blunt the emergence and spread of zoonotic diseases through better understanding of human, animal, and environmental interactions that enable animal-borne diseases to break into human populations. The One Health High Level Expert Panel will advise the World Health Organization (WHO), […] Continue reading -> Pandemic Treaty & Other New COVID Initiatives Grab Center Stage At World Health Assembly 20/05/2021 Pokuaa Oduro-Bonsrah Conquering the COVID-19 pandemic will inevitably be the main topic for discussion at the impending 74th session of the World Health Assembly, which begins Monday, 24 May. Global health experts weighed in this week at a series of briefings on what to expect from at the upcoming event. Geneva Solution’s Pokuaa Oduro Bonsrah reports: The […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Treaty & Other New COVID Initiatives Grab Center Stage At World Health Assembly 20/05/2021 Pokuaa Oduro-Bonsrah Conquering the COVID-19 pandemic will inevitably be the main topic for discussion at the impending 74th session of the World Health Assembly, which begins Monday, 24 May. Global health experts weighed in this week at a series of briefings on what to expect from at the upcoming event. Geneva Solution’s Pokuaa Oduro Bonsrah reports: The […] Continue reading -> ‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘IP Monopoly Capitalism’ – A ‘Virus’ To Society During COVID-19 19/05/2021 Raisa Santos Governments and pharmaceutical companies alike must work together in combating the ‘virus of intellectual property (IP) monopolies over COVID-19 vaccines – which further exacerbates inequality and lack of access to vaccines for vulnerable groups. That was the uptake of a group of experts speaking at a webinar Wednesday on “The Virus of IP Monopoly Capitalism”’ […] Continue reading -> Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sustainable COVAX Vaccine Funding & Voluntary Manufacturing Licenses are Better Solutions than IP Waiver, Says IFPMA Head 16/05/2021 Elaine Ruth Fletcher In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Chinese Sinopharm Vaccine Gets WHO Green Light – Positioning It To Resupply COVAX Global Vaccine Facility 07/05/2021 Madeleine Hoecklin The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease. The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading -> Posts navigation Older postsNewer posts